Newark, United States
Navinata Health is a health care and pharmaceutical startup, founded in 2015 and headquartered in the United States. The company aims to provide physicians and patients with convenient, customized, and credible education along with expert insight.
Through their Knowledge Exchange Platform, physicians can SHARE their insights, LEARN about new and innovative therapies through tailored education, and CONNECT directly with leading experts, particularly in the areas of cancer, respiratory and neurological disorders, and auto-immune diseases.
In addition to their physician-focused platform, Navinata Health has launched a new Patient Educational Platform for newly diagnosed cancer patients, with a current focus on metastatic NSCLC and upcoming programs in breast cancer, colorectal cancer, multiple myeloma, and more.
The company received a $125.00K convertible note investment from Newark Ventures on 15 August 2016.
Navinata Health's efforts to bridge the gap between physicians, patients, and expert knowledge positions them as a promising player in the healthcare and pharmaceutical industries.
